BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bornschein J, Weigt J, Selgrad M, Malfertheiner P. Molecular aspects in the diagnosis of gastric cancer. Expert Opin Med Diagn 2009;3:585-96. [PMID: 23495987 DOI: 10.1517/17530050902862175] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
Number Citing Articles
1 Wang HL, Zhou PY, Liu P, Zhang Y. Abnormal FHIT protein expression may be correlated with poor prognosis in gastric cancer: a meta-analysis. Tumour Biol 2014;35:6815-21. [PMID: 24729090 DOI: 10.1007/s13277-014-1936-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
2 Zhang J, Wang G, Chu SJ, Zhu JS, Zhang R, Lu WW, Xia LQ, Lu YM, Da W, Sun Q. Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling. Oncotarget 2016;7:16180-93. [PMID: 26921249 DOI: 10.18632/oncotarget.7568] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 6.8] [Reference Citation Analysis]
3 Tian T, Xiao L, Du J, Zhu X, Gu Y, Qin N, Yan C, Liu L, Ma H, Jiang Y, Chen J, Yu H, Dai J. Polymorphisms in CARS are associated with gastric cancer risk: a two-stage case-control study in the Chinese population. Gastric Cancer 2017;20:940-7. [PMID: 28409418 DOI: 10.1007/s10120-017-0717-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]